— Textron Inc (NYSE: TXT) reported third-quarter 2019 earnings of $0.95 per share, vs. $0.85 per share expected.
— Revenues grew 2% to $3.26 billion, vs. $3.32 billion expected.
— Narrows full-year EPS guidance to $3.70 to $3.80.
— Outlook on full-year cash flow revised to a range of $600 million to $700 million, from $700 million to $800 million.
— TXT shares rose 1% immediately following the announcement.
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly recovering from the pandemic. Several pharmaceuticals firms have
Shares of American Airlines Group (NASDAQ: AAL) have gained 42% since the beginning of this year and 50% over the past 12 months. Despite this, there is a mixed sentiment